We are live on ! Find out more
IRD

Opus Genetics
IRD

49 hedge funds and large institutions have $6.78M invested in Opus Genetics in 2024 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 12 increasing their positions, 11 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,850% more call options, than puts

Call options by funds: $234K | Put options by funds: $12K

9% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 11

2% less funds holding

Funds holding: 50 → 49 (-1)

3.05% less ownership

Funds ownership: 16.65% → 13.6% (-3%)

11% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 9

40% less capital invested

Capital invested by funds: $11.3M → $6.78M (-$4.56M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
49
Holders Change
-1
Holders Change %
-2%
% of All Funds
0.71%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
8
Increased
12
Reduced
11
Closed
9
Calls
$234K
Puts
$12K
Net Calls
+$222K
Net Calls Change
-$201K

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$282K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$163K
3
Citadel Advisors
Citadel Advisors
Florida
+$163K
4
Mackenzie Financial
Mackenzie Financial
Ontario, Canada
+$104K
5
BCM
Bridgeway Capital Management
Texas
+$92.8K

Top Sellers

Rank Fund Capital Flow
1
RHJA
Rice Hall James & Associates
California
-$710K
2
MCM
MAI Capital Management
Ohio
-$426K
3
Squarepoint
Squarepoint
New York
-$184K
4
AFM
Anson Funds Management
Texas
-$149K
5
Morgan Stanley
Morgan Stanley
New York
-$142K
Name Holding Trade Value Shares
Change 		Change in
Stake
CAPTRUST Financial Advisors
26
CAPTRUST Financial Advisors
North Carolina
$36.2K – – –
VF
27
Virtu Financial
New York
$36K +$45K +17,752 New
Prudential Financial
28
Prudential Financial
New Jersey
$35K +$10.1K +4,000 +30%
Osaic Holdings
29
Osaic Holdings
Arizona
$33.2K -$2.03K -800 -5%
BFC
30
Bedel Financial Consulting
Indiana
$30.1K – – –
UBS Group
31
UBS Group
Switzerland
$28.6K +$22.4K +8,830 +164%
SFO
32
Stokes Family Office
Louisiana
$24.4K – – –
LNC
33
Lincoln National Corp
Pennsylvania
$23.9K +$507 +200 +2%
STA
34
Summit Trail Advisors
New York
$21.2K +$26.7K +10,545 New
TRCT
35
Tower Research Capital (TRC)
New York
$14.8K +$18.7K +7,376 New
Wells Fargo
36
Wells Fargo
California
$5.96K +$38 +15 +0.5%
Simplex Trading
37
Simplex Trading
Illinois
$4K -$20K -7,895 -79%
National Bank of Canada
38
National Bank of Canada
Quebec, Canada
$3.42K – – –
CFGS
39
Concourse Financial Group Securities
Alabama
$2.38K – – –
TFA
40
Toth Financial Advisory
Virginia
$2.01K – – –
CWM
41
CarsonAllaria Wealth Management
Illinois
$2.01K – – –
OIA
42
Optimum Investment Advisors
Illinois
$2.01K – – –
OPTFSNA
43
Old Point Trust & Financial Services N A
Virginia
$1K +$1.27K +500 New
NS
44
NBC Securities
Alabama
$1K – – –
HI
45
Harbour Investments
Wisconsin
$80 +$101 +40 New
RhumbLine Advisers
46
RhumbLine Advisers
Massachusetts
$58 – – –
IGWM
47
ICA Group Wealth Management
Colorado
$20 -$51 -20 -67%
FWM
48
FSA Wealth Management
Massachusetts
$10 – – –
Squarepoint
49
Squarepoint
New York
– -$184K -61,152 Closed
AFM
50
Anson Funds Management
Texas
– -$149K -49,339 Closed
1
2
3

IRD Hedge Fund Activity: Q1 2024 in Review

49 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Opus Genetics (IRD) for Q1 2024, worth a combined $6.78M — down 40% from $11.3M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of IRD and 8 opened new positions — a net loss of 1 holder — while 11 trimmed existing stakes and 12 added.

The largest buyer was Renaissance Technologies, adding an estimated $282K. The largest seller was Rice Hall James & Associates, cutting an estimated $710K.

  • 49 institutional investors held Opus Genetics (IRD) as of Q1 2024, down from 50 in Q4 2023.
  • Funds reported $6.78M of Opus Genetics stock for Q1 2024, down 40% quarter-over-quarter.
  • 8 funds opened new Opus Genetics positions in Q1 2024 and 9 closed out, a net change of -1 holder.
  • The largest Opus Genetics buyer in Q1 2024 was Renaissance Technologies, an estimated $282K added.
  • The largest Opus Genetics seller in Q1 2024 was Rice Hall James & Associates, an estimated $710K sold.

Based on aggregated 13F filings for Q1 2024.